Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions Presented at the 54th Annual Meeting of the American Society for Radiation Oncology, Boston, MA, Oct 28-31, 2012.

International Journal of Radiation Oncology Biology Physics

Volumn 93, Issue 3, 2015, Pages 507-515

  Otter, Sophie ^a   Schick, Ulrike ^a,b   Gulliford, Sarah ^a,b   Lal, Punita ^c   Franceschini, Davide ^d   Newbold, Katie ^a,b   Nutting, Christopher ^a,b   Harrington, Kevin ^a,b   Bhide, Shreerang ^a,b,d  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIOTHERAPY; CHEMOTHERAPY; DOSIMETRY; FAULT TOLERANT COMPUTER SYSTEMS; LOGISTIC REGRESSION; NATURAL LANGUAGE PROCESSING SYSTEMS; ONCOLOGY;

ATLAS-BASED METHODS; DOSE-VOLUME HISTOGRAMS; DOSIMETRIC PARAMETER; METHODS AND MATERIALS; MULTIVARIATE ANALYSIS; RADIATION ONCOLOGY; RECEIVER OPERATING CURVES; SQUAMOUS CELL CARCINOMA;

MULTIVARIANT ANALYSIS;

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ATLAS OF COMPLICATION INCIDENCE METHOD; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DOSIMETRY; DYSPHAGIA; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NASOPHARYNX CANCER; ORAL MUCOSITIS; PHARYNGEAL DYSPHAGIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; COMPUTER GRAPHICS; DEGLUTITION DISORDERS; HEAD AND NECK NEOPLASMS; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; MIDDLE AGED; MUCOSITIS; ORGANS AT RISK; PROCEDURES; RADIATION RESPONSE; RADIOGRAPHY; RADIOTHERAPY DOSAGE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; COMPUTER GRAPHICS; DEGLUTITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUCOSITIS; MULTIVARIATE ANALYSIS; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; ROC CURVE;

EID: 84942319359     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.07.2263     Document Type: Conference Paper

References (34)

1. J.P. Pignon, A. le Maitre, E. Maillard, and et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
2. J.L. Lefebvre Laryngeal preservation in head and neck cancer: Multidisciplinary approach Lancet Oncol 7 2006 747 755
3. A. Trotti, L.A. Bellm, J.B. Epstein, and et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review Radiother Oncol 66 2003 253 262
4. S. El-Sayed, and N. Nelson Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials J Clin Oncol 14 1996 838 847
5. G. Russo, R. Haddad, M. Posner, and et al. Radiation treatment breaks and ulcerative mucositis in head and neck cancer Oncologist 13 2008 886 898
6. D.L. Schwartz, K. Hutcheson, D. Barringer, and et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 78 2010 1356 1365
7. S.A. Bhide, K.J. Harrington, and C.M. Nutting Otological toxicity after postoperative radiotherapy for parotid tumours Clin Oncol (R Coll Radiol) 19 1 2007 77 82
8. A. Eisbruch, M. Schwartz, C. Rasch, and et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60 2004 1425 1439
9. A.B. Miah Dose-response analysis of parotid gland function: what is the best measure of xerostomia? Radiother Oncol 106 3 2013 341 345
10. G. Sanguineti, G.B. Guinn, B.C. Parker, and et al. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer Int J Radiat Oncol Biol Phys 79 2011 52 59
11. G. Sanguineti, M.P. Sormani, S. Marur, and et al. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer Int J Radiat Oncol Biol Phys 83 2012 235 242
12. J. Werbrouck, K. De Ruyck, F. Duprez, and et al. Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: Influence of dose and association with genetic polymorphisms in DNA DSB repair genes Int J Radiat Oncol Biol Phys 73 2009 1187 1195
13. A. Jackson, E.D. Yorke, and K.E. Rosenzweig The atlas of complication incidence: A proposal for a new standard for reporting the results of radiotherapy protocols Semin Radiat Oncol 16 2006 260 268
14. A.B. Miah A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes Br J Cancer 112 1 2015 32 38
15. A.B. Miah Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers Int J Radiat Oncol Biol Phys 82 2 2012 539 547
16. C. Powell Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain Radiother Oncol 110 3 2014 416 421
17. A.C. Wilkins Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: a matched-pair analysis Oral Oncol 49 6 2013 615 619
18. S. Bhide Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site Med Dosim 32 3 2007 188 195
19. S.A. Bhide Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer Radiother Oncol 93 3 2009 539 544
20. M.E. Christianen, J.A. Langendijk, H.E. Westerlaan, and et al. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning Radiother Oncol 101 2011 394 402
21. National Cancer Institute Common Terminology Criteria for Adverse Events v3.0 NCI, NIH, DHHS. August 9, 2006 NIH publication # 09-7473. Available at http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3.pdf. Accessed August 20, 2015.
22. H.R. Withers, H.D. Thames Jr., and L.J. Peters A new isoeffect curve for change in dose per fraction Radiother Oncol 1 1983 187 191
23. J.F. Fowler Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling Clin Oncol (R Coll Radiol) 19 2007 8 22
24. I. Beetz, C. Schilstra, A. van der Schaaf, and et al. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: The role of dosimetric and clinical factors Radiother Oncol 105 2012 101 106
25. R Core Team R: A language and environment for statistical computing 2013 R Foundation for Statistical Computing Vienna, Austria Available at: www.R-project.org/. Accessed August 20, 2015
26. W.J. Youden Index for rating diagnostic tests Cancer 3 1950 32 35
27. A. Jackson, L.B. Marks, S.M. Bentzen, and et al. The lessons of QUANTEC: Recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome Int J Radiat Oncol Biol Phys 76 3 Suppl 2010 S155 S160
28. D.I. Rosenthal, J.S. Lewin, and A. Eisbruch Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer J Clin Oncol 24 2006 2636 2643
29. K. De Ruyck, F. Duprez, J. Werbrouck, and et al. A predictive model for dysphagia following IMRT for head and neck cancer: Introduction of the EMLasso technique Radiother Oncol 107 2013 295 299
30. A. Eisbruch, H.M. Kim, J.E. Terrell, and et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 695 704
31. J.A. Dean, L.C. Welsh, S.L. Gulliford, and et al. A novel method for delineation of oral mucosa for radiotherapy dose-response studies Radiother Oncol 115 2015 63 66
32. Z. Wang, B. Xu, D. Lin, and et al. XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population Lung Cancer 62 2008 99 104
33. M.R. Kelley, Y. Jiang, C. Guo, and et al. Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathy PLoS One 9 2014 e106485
34. L. Masterson, D. Moualed, Z.W. Liu, and et al. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis of current clinical trials Eur J Cancer 50 2014 2636 2648